The purpose is to develop a Research, Measurement, Assessment, Design, and Analysis (RMADA) IDIQ [Indefinite Delivery, Indefinite Quantity] to respond to expanded needs of the Patient Protection and Affordable Care ACT (ACA) and Health Care reform ACT (HCERA). The work awarded under the RMADA will involve the design, implementation and evaluation of a broad range of research and/or payment and service delivery models to test their potential for reducing expenditures for Medicare, Medicaid, CHIP, and uninsured beneficiaries while maintaining or improving quality of care.
While the contract is to be an IDIQ contract, meaning that the quantity of work is variable and therefore the price to be paid is not fixed, documents accompanying the contract indicate the maximum is set at $7 billion over the life of the contract:
No comments:
Post a Comment